(E)-N-(3-(4,5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

(E)-N-(3-(4,5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide

● Auf Lager

Katalog-Nr.::VE0022770
CAS-Nr.::N/A
Summenformel::C12H13N3O6
Molare Masse::295.25 g/mol

Zusätzliche Informationen zu (E)-N-(3-(4 | 5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide

Parent drug

Cabozantinib

IUPAC-Name

(E)-N-(3-(4, 5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

COC1=C(OC)C=C(C(/C=C/N(N=O)C)=O)C([N+]([O-])=O)=C1

InChI

InChI=1S/C12H13N3O6/c1-14(13-17)5-4-10(16)8-6-11(20-2)12(21-3)7-9(8)15(18)19/h4-7H, 1-3H3/b5-4+

Beschreibung

The compound (E)-N-(3-(4 | 5-dimethoxy-2-nitrophenyl)-3-oxoprop-1-en-1-yl)-N-methylnitrous amide is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines | including those from USP | EMA | JP | and BP. It is ideal for critical applications such as analytical method development | method validation (AMV) | and quality control (QC) | especially in the production of Cabozantinib. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | this product delivers the precision required for reliable results. Additionally | it includes a detailed Structure Elucidation Report (SER) | ensuring accuracy and dependability for advanced analytical purposes.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url